Australia markets closed

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
11.060-0.440 (-3.83%)
At close: 03:47PM HKT

Zylox-Tonbridge Medical Technology Co., Ltd.

Building 1
1st and 2nd Floors No. 18 Keji Avenue Yuhang District
Hangzhou 311121
China
86 571 8861 0082
https://www.zyloxmedical.com

Sector(s):Β Healthcare
Industry:Β Medical Devices
Full-time employees:Β 487

Key executives

NameTitlePayExercisedYear born
Dr. Zhong ZhaoFounder, Chairman & CEO655.48kN/A1967
Mr. Yang XieSr. VP of Sales & Marketing and Exec. Director307.34kN/A1970
Dr. Zheng LiSr. VP, GM of Neurovascular Bus. & Exec. Director498.63kN/A1978
Mr. Quanwei YuanCFO & Joint Company Sec.N/AN/A1980
Dr. Ning PanSr. VP of R&D for peripheral vascular businessN/AN/A1967
Mr. Kai Cheong Cheung ACCA, CPA, F.C.A., FCCA, FCPAJoint Company Sec.N/AN/A1975
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices China and internationally. It primarily offers ThromBite Clot Retriever Device, which is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke; Balloon Guiding Catheter; Cylone Aspiration Catheter; ZENFLEX Pro Peripheral Drug-eluting Stent System for complex lesions and restenotic symptomatic lesions; ZENFlex Peripheral Stent System to deliver a self-expanding stent to the iliac artery, superficial femoral arteries, and/or proximal popliteal arteries through a 6F delivery system; and drug-coated percutaneous transluminal angioplasty (PTA) Balloon Catheters that are indicated for PTA of stenosis or occlusion lesions in iliac, femoral, or popliteal arteries. The company also provides Ton-Bridge extra soft coils for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, such as arteriovenous malformations and arteriovenous fistulae; microcatheter for coiling; distal access catheter; glycine micro catheter for professional physician to selectively inject or input control medium and/or embolic materials, and/or appropriate devices; Intracranial PTA balloon catheter; vascular snare; and snare retrieval kit for IVC filter. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Zhejiang, the People's Republic of China.

Corporate governance

Zylox-Tonbridge Medical Technology Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.